View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Novo Nordisk Pharmatech Selects Azelis to Distribute its Quaternary Ammonium Compounds in Germany, Spain, Portugal, the UK, and Ireland

Novo Nordisk Pharmatech has entered an agreement with Azelis for the distribution of quaternary ammonium compounds (quats) to the pharmaceutical and medical device markets in Germany, Spain Portugal, UK and Ireland.

Market segment director of pharma at Azelis Matthew Dickman explains: "Novo Nordisk Pharmatech is the industry leader in pharmaceutical grade quats and we are delighted they have chosen Azelis Pharma as their distribution partner for the development of these markets. Novo Nordisk Pharmatech’s quats complement an existing Azelis portfolio of pharma antimicrobials.

"Alongside established uses of quats, our Pharma experts see potential new applications in the growing wound care market. Our local teams, who work with customers to support both their current and NPD requirements, will be investigating these options in the coming period."

Novo Nordisk Pharmatech manufactures its quats (Benzalkonium Chloride, Cetrimide, and Cetyl Trimethyl Ammonium Bromide, including customised grades) to the highest current good manufacturing practice (cGMP) standards. Its site (Koge / Denmark) is audited by the Danish Medicines Agency and US Food and Drug Administration (FDA). Products comply with the latest major pharmacopoeia and are supported by certificates of suitability (CEP), drug master files (DMF), and a comprehensive package of regulatory and quality assurance documents.

Sales and marketing director at Novo Nordisk Pharmatech Steve Profit said: "We are very happy to work with Azelis as our distribution partner for pharmaceuticals. Novo Nordisk Pharmatech’s FeF™Quats products fit perfectly with Azelis existing antimicrobial portfolio enabling the customers to take advantage of these synergies. We wish to give the best service to our customers and the local pharma teams of Azelis are experts in working with customers to support their current and product development requirements."

About Azelis

Azelis is a global speciality chemicals distributor providing a diverse range of innovative products and services. Dedicated teams serve customers in industries such as the personal care, pharmaceutical, food and health, animal nutrition, specialty agricultural / horticultural, and homecare sectors.

With sourcing and distribution channels in every major market around the world, Azelis has a corporate service centre in Antwerp, Belgium. It offers chemical producers market penetration, in-depth local knowledge, value-added services and tailored multi-territory solutions. The company has a turnover of €1.5 billion and employs around 1,500 knowledgeable people located in more than 45 facilities in 35 countries across Europe, the Middle East, and Asia (EMEA), as well as the Asia Pacific and Americas regions.

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology